Prelude Capital Management’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-722,206
Closed -$12.1M 1650
2022
Q4
$12.1M Buy
722,206
+108,394
+18% +$1.83M 0.63% 16
2022
Q3
$10.5M Buy
+613,812
New +$9.64M 0.38% 29

Prelude Capital Management's ONEM Position: Q1 2023 in Review

Prelude Capital Management sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 722,206 shares — an estimated $12.1M sold.

Prelude Capital Management first reported a position in ONEM in Q3 2022 and held it in 2 quarters. The position peaked at $12.1M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Prelude Capital Management reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Prelude Capital Management sold 722,206 1Life Healthcare shares in Q1 2023, an estimated $12.1M.
  • Prelude Capital Management first reported a position in 1Life Healthcare in Q3 2022 and held it in 2 quarters.
  • Prelude Capital Management's 1Life Healthcare position peaked at $12.1M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.